Reduced miRNA‐124 expression acutely (up to 6 h) after AIS negatively correlated to outcome (NIHSS) and IL‐6 levels (Qi et al., 2021) while increased expression in circulating EVs at 24 h from symptom onset positively correlated with NIHSS and IL‐6 levels (Ji et al., 2016). This evidence concerns the gene IL6 and androgen insensitivity syndrome.